pages:
-
AHEC Point of Service Maint & Enhancement
-
AHOD1331 A Randomized Phase III Study of Brentuximab Vedotin (IND#117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents
-
AHOD1331-A Randomized Phase III Study of Brentuximab Vedotin for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma in Children and Adolescents
-
AHOD1721, Risk-based, Response-Adapted, Phase ll Open- Label Trail of Nivolumab+Brentuximab Vedotin(N+Bv) for Children,Adolescents, and Young Adults with Relapsed/ Refractory (R/R) CD30+ Classic Hodgkin Lymphoma (cHL) after Failure of First -Line Therapy, followed by Brentuximab+Bendamustine(Bv+B) for participants with a suboptimal response;CheckMate 744:Checkpoint Pathway and Nivolumab Clinical Trail Evaluation.
-
AHOD1822 -- AnOpen-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)
-
AI4CHRON - An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform
-
AIACC Needs Assessment
-
AIDS Clinical Trial Group (ACTG 5324) -- A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with No Intensification or Intensification with Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
-
Aids Clinical Trial Group: ACTG
-
AIDS Clinical Trials Group (ACTG)
-
Aids Clinical Trials Group (ACTG) - TSG/Research Science Committee
-
AIDS Clinical Trials Group (ACTG) A5332/A5340 Salary Support
-
AIDS Clinical Trials Group Network (ACTG)
-
AIDS Clinical Trials Group: Protocol Funds
-
AIDS Clinical Trials Group: Protocol Funds FTE Funding
-
AIDS Education & Training Centers Florida/Caribbean AIDS Education and Training Center (AETC)
-
AIDS Education and Training Centers Program
-
AIM's Writing for Healing: A Workshop for Individuals Living with Paralysis
-
Airway Stem Cell Activation in the Mitigation of Halogen-Induced Lung Injury
-
Airways Clinical Research Center (ACRC)
-
Airways Clinical Research Centers (ACRC)
-
Airways Clinical Research Centers (ACRC) Network
-
Airways Clinical Research Centers (ACRC) Network
-
Airways Clinical Research Centers (ALA-ACRC) Network
-
AKI Sample NGAL Test™ Validation Protocol
-
Alabama - Clinical Trials Unit
-
Alabama Academy of Science Student Research Grant
-
Alabama Academy of Science Student Research Grant
-
Alabama Academy of Science Student Research Grant
-
Alabama Academy of Sciences Research Awards 2015-2016
pages:
